RVL Pharmaceuticals plc
Hedge Funds Holdings
Last updated:
RVL Pharmaceuticals plc‘s stocks are currently a part of 23 hedge funds’ portfolios, which represents 6.79% of the total amount of its stocks outstanding. This makes up a total of 6.09M shares of RVL Pharmaceuticals plc. Compared to the previous quarter, the number fell by -76.01% or -19.30M shares fewer. As for the holding position changes, 8.7% (2) of current hedge fund investors increased the number of shares held, 26.09% (6) of current holders sold a part of the shares held, and 4.35% (1) closed the holdings completely. 4 hedge funds are new holders of RVL Pharmaceuticals plc stock in Q1 2023, it is 17.39% of total holders.
Hedge funds holding RVL Pharmaceuticals (Q4 2018 – Q1 2023)
| Q4 2018 | 34 |
|---|---|
| Q1 2019 | 34 |
| Q2 2019 | 42 |
| Q3 2019 | 40 |
| Q4 2019 | 49 |
| Q1 2020 | 60 |
| Q2 2020 | 64 |
| Q3 2020 | 62 |
| Q4 2020 | 60 |
| Q1 2021 | 54 |
| Q2 2021 | 44 |
| Q3 2021 | 34 |
| Q4 2021 | 29 |
| Q1 2022 | 31 |
| Q2 2022 | 33 |
| Q3 2022 | 45 |
| Q4 2022 | 36 |
| Q1 2023 | 23 |
Hedge funds changes in RVL Pharmaceuticals positions (Q4 2018 – Q1 2023)
| Q4 2018 | 34 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2019 | 7 | 10 | 10 | 7 | 0 |
| Q2 2019 | 14 | 11 | 12 | 5 | 0 |
| Q3 2019 | 7 | 16 | 10 | 9 | -2 |
| Q4 2019 | 13 | 22 | 8 | 4 | 2 |
| Q1 2020 | 19 | 26 | 11 | 8 | -4 |
| Q2 2020 | 16 | 26 | 15 | 10 | -3 |
| Q3 2020 | 13 | 27 | 14 | 16 | -8 |
| Q4 2020 | 7 | 22 | 22 | 8 | 1 |
| Q1 2021 | 8 | 20 | 16 | 14 | -4 |
| Q2 2021 | 10 | 6 | 21 | 20 | -13 |
| Q3 2021 | 1 | 12 | 12 | 11 | -2 |
| Q4 2021 | 8 | 6 | 10 | 13 | -8 |
| Q1 2022 | 8 | 9 | 6 | 6 | 2 |
| Q2 2022 | 6 | 4 | 8 | 3 | 12 |
| Q3 2022 | 18 | 5 | 8 | 6 | 8 |
| Q4 2022 | 1 | 13 | 6 | 10 | 6 |
| Q1 2023 | 4 | 2 | 6 | 1 | 10 |
Hedge funds changes in RVL Pharmaceuticals stock options (Q4 2018 – Q1 2023)
| Q4 2018 | 0 | 0 |
|---|---|---|
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 16,000 | 0 |
| Q1 2022 | 111,000 | 6,000 |
| Q2 2022 | 83,000 | 0 |
| Q3 2022 | 441,000 | 133,000 |
| Q4 2022 | 194,712 | 2,240 |
| Q1 2023 | 49,284,000 | 0 |